Brief: Janssen To Acquire Investigational Bermekimab From Xbiotech

XBiotech

07/12/2019 07:47

Dec 7 (Reuters) - Janssen Biotech :
    * JANSSEN TO ACQUIRE INVESTIGATIONAL BERMEKIMAB FROM
XBIOTECH
    * JANSSEN BIOTECH- UNDER TERMS OF AGREEMENT, JANSSEN WILL
ASSUME
RESPONSIBILITY FOR CLINICAL PROGRAM, WORKING CLOSELY WITH
XBIOTECH
    * JANSSEN BIOTECH -  WILL PAY XBIOTECH A PURCHASE PRICE OF
$750
MILLION FOR RIGHTS TO BERMEKIMAB

Source text for Eikon:  ID:nPn3WWDK1a 
Further company coverage:  XBIT.O 

 ((Reuters.Briefs@thomsonreuters.com;))